Abstract:Most agents that damage DNA act through posttranslational modifications of p53 and activate its downstream targets. However, whether cellular responses to nucleoside analogue-induced DNA damage also operate through p53 posttranslational modification has not been reported. In this study, the relationship between p53 activation and its posttranslational modifications was investigated in the human cancer cell lines A549 and HCT116 in response to 5-aza-2 '-deoxycytidine (5-aza-CdR) or cytarabine treatment. 5-Aza-CdR induces p53 posttranslational modifications through activation of an ATM- and Rad3-related (ATR) signaling pathway, and 5-aza-CdR-induced association of replication protein A with chromatin is required for the binding of ATR to chromatin. Upon treatment with 5-aza-CdR, ATR activation is clearly associated with p53 phosphorylation at Ser(15), but not at Thr(18), Ser(20), or Ser(37). This specific p53 phosphorylation at Ser15 in turn results in acetylation of p53 at Lys(320) and Lys(373)/Lys(382) through transcriptional cofactors p300/CBP-associated factor and p300, respectively. These p53 posttranslational modifications are directly responsible for 5-aza-CdR induced p21(Waf1/Cip1) expression because the binding activity of acetylated p53 at Lys(320)/Lys(373)/ Lys(382) to the p21(Waf1/Cip1) promoter, as well as p21(Waf1/Cip1) expression itself are significantly increased after 5-aza-CdR treatment. It is of interest that p53 phosphorylation at Ser15 and acetylations at Lys(320)/Lys(373)/ Lys382 mutually interact in the 5-aza-CdR induced p21(Waf1)/(Cip1) expression shown by transfection of artificially mutated p53 expression vectors including S15A, K320R, and K373R/K382 into p53-null H1299 cells. These data taken together show for the first time that 5-aza-CdR activates the ATR signaling pathway, which elicits a specific p53 phosphorylation-acetylation cascade to induce p21(Waf1/Cip1) expression.

The CXXC Finger 5 Protein is Required for DNA Damage-Induced P53 Activation

Loss of Cell Division Cycle‑associated 5 Promotes Cell Apoptosis by Activating DNA Damage Response in Clear Cell Renal Cell Carcinoma.

JMJD5 Interacts with P53 and Negatively Regulates P53 Function in Control of Cell Cycle and Proliferation.

PDCD5 Interacts with P53 and Functions As a Positive Regulator in the P53 Pathway.

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

Regulation of the DNA damage response by p53 cofactors.

PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response

An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of P53/p21waf1/cip1 in Response to 5-Aza-2′-deoxycytidine Treatment

A Positive Role for C-Abl in Atm and Atr Activation in DNA Damage Response

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

DNA-dependent Protein Kinase-independent Activation of p53 in Response to DNA Damage

The Catalytic Subunit of DNA-dependent Protein Kinase Selectively Regulates P53-Dependent Apoptosis but Not Cell-Cycle Arrest.

Induction Of Sox4 By Dna Damage Is Critical For P53 Stabilization And Function

Coordination of the Nuclear and Cytoplasmic Activities of P53 in Response to DNA Damage

Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage

Pdcd5-Regulated Cell Fate Decision after Ultraviolet-Irradiation-Induced Dna Damage

Cell Fate Decision Mediated by P53 Pulses

Tumor and Stem Cell Biology ING 5 Is a Tip 60 Cofactor That Acetylates p 53 in Response to DNA Damage

Gadd45a contributes to p53 stabilization in response to DNA damage

Differential Regulation of Apak by Various Dna Damage Signals